You Can Now Get Weight-Loss Drugs Right From Eli Lilly

[ad_1] Eli Lilly started a new online service offering telehealth prescriptions and direct home delivery of its new anti-obesity drug Zepbound, an unusual move into the drug supply chain by…

Roche Strikes Deal to Buy Drug Developer Carmot Therapeutics for $2.7 Bln

[ad_1] Roche aims to buy Carmot Therapeutics, a California-based pharmaceutical firm developing drugs to treat obesity and diabetes. The Swiss pharmaceutical company said it has entered an agreement to acquire…

Wegovy-Maker Novo Nordisk to Spend More Than $2 Billion Boosting Production in France

[ad_1] Pharmaceutical giant Novo Nordisk said it will invest more than 16 billion Danish kroner ($2.34 billion) in its French production site as it seeks to meet rising demand for…

Wegovy Maker Novo Nordisk to Spend $6 Billion Boosting Production Capacity

[ad_1] Novo Nordisk, the Danish pharmaceutical giant that makes the blockbuster Wegovy obesity drug, said it will invest more than $6 billion to boost production capacity. Copyright ©2023 Dow Jones…

Obesity Drug Demand Outstrips Supply

[ad_1] Eli Lilly’s blockbuster diabetes medication Mounjaro is expected to receive Food and Drug Administration approval as an obesity treatment before the end of the year, which would lead to…

Biocon, Juno Pharma ink pact for commercialisation of Liraglutide in Canada

[ad_1] Global biopharmaceutical company Biocon announced on Friday a partnership with Juno Pharmaceuticals, a specialty pharmaceutical firm based in Canada, for the commercialisation of Liraglutide, a drug-device combination intended for…

Eli Lilly Diabetes, Obesity Head Mike Mason to Retire

[ad_1] The head of Eli Lilly’s burgeoning diabetes and obesity franchise is retiring at the end of the year. Mike Mason is leaving after 34 years with the company. [ad_2]…

Contamination Is Found at Novo Nordisk Plant in U.S.

[ad_1] Novo Nordisk found bacteria in batches of the main ingredient for a diabetes pill that is a cousin to popular diabetes and weight-loss drugs and was made at a North…

Ozempic Settles the Obesity Debate: It’s Biology Over Willpower

[ad_1] Weight-loss drugs affect the brain in ways that help researchers understand how the body regulates weight. [ad_2] Source link

Weight-Loss Drug Wegovy Cuts Heart Attack, Stroke Risk by 20% in New Study

[ad_1] Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. [ad_2] Source link